Abstract:Control over of biological processes can potentially be therapeutically regulated through localized biomolecular deliveries. While implantable hydrogels can provide localized therapeutic deliveries, they do not traditionally provide the temporally complex therapeutic delivery profiles required to regulate complex biological processes. Ionically crosslinked alginate hydrogels have been shown to release encapsulated payloads in response to a remotely applied ultrasonic stimulus, thus potentially enabling more temporally complex therapeutic delivery profiles. However, thorough characterizations of how different types of therapeutic payloads are retained and ultrasonically released need to be performed. Additionally, the impact of potentially disruptive ultrasonic stimulations on hydrogel structure and temperature need to be characterized to better understand what range of ultrasonic signals can be used to trigger release. To perform these characterizations, calcium-crosslinked alginate hydrogels were loaded with various model macromolecules (dextrans), chemotherapeutics, and protein signaling factors and exposed to a variety of single-pulse and multi-pulse ultrasonic signals at various amplitudes and durations. In response to single-pulsed ultrasonic exposures, quantifications of molecular release, degree of gel erosion, and increase in hydrogel temperature revealed that the ultrasonic stimulations required for statistically significant therapeutic deliveries often eroded and heated the gels to unacceptable levels. However, multi-pulse ultrasonic exposures were shown to achieve significant amounts of therapeutic release while keeping gel erosion and temperature increase at modest levels. Finally, experiments were performed demonstrating that ultrasonic stimulation could be used to generate drug release profiles shown to have potential therapeutic benefits (e.g., pulsatile and sequential anticancer delivery profiles). This work underscores the potential of using ultrasonically responsive polymeric hydrogels for providing on-demand control over more complex therapeutic deliver profiles and enhancing drug delivery strategies in cancer therapies and beyond.

Corked Microcapsules Enabling Controlled Ultrasound-Mediated Protein Delivery

Generation of Uniform Polymer Eccentric and Core-Centered Hollow Microcapsules for Ultrasound-Regulated Drug Release

Ultrasound-actuated drug delivery with acoustic percolation switches

Direction-Specific Release from Capsules with Homogeneous or Janus Shells Using an Ultrasound Approach

Controlled Drug Release from Ultrasound-Visualized Elastic Eccentric Microcapsules Using Different Resonant Modes

State-of-the-art materials for ultrasound-triggered drug delivery

Ultrasound-Triggered Smart Drug Release from Multifunctional Core-Shell Capsules One-Step Fabricated by Coaxial Electrospray Method

Composite Silica Nanoparticle/polyelectrolyte Microcapsules with Reduced Permeability and Enhanced Ultrasound Sensitivity

Ultrasonic Generation of Pulsatile and Sequential Therapeutic Delivery Profiles from Calcium-Crosslinked Alginate Hydrogels

Ultrasound-responsive microparticles from droplet microfluidics

Ultrasound-Mediated Polymeric Micelle Drug Delivery

Ultrasound-Mediated Drug Delivery: Sonoporation Mechanisms, Biophysics, and Critical Factors

Ultrasound-responsive microbubbles and nanodroplets: A pathway to targeted drug delivery

Targeted drug release from stable and safe ultrasound-sensitive nanocarriers

Spatiotemporal Drug Delivery Using Laser-Generated-focused Ultrasound System

Micelles and nanoparticles for ultrasonic drug and gene delivery

Stimuli-responsive Biodegradable Poly(methacrylic Acid) Based Nanocapsules for Ultrasound Traced and Triggered Drug Delivery System.

Theranostic Multilayer Capsules for Ultrasound Imaging and Guided Drug Delivery.

Low Frequency Ultrasound Triggering Drug Release from Improved PLGA Microcapsules in Vitro

Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery